BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nordin AH, Husna SMN, Ahmad Z, Nordin ML, Ilyas RA, Azemi AK, Ismail N, Siti NH, Ngadi N, Azami MSM, Mohamad Norpi AS, Reduan MFH, Osman AY, Pratama DAOA, Nabgan W, Shaari R. Natural Polymeric Composites Derived from Animals, Plants, and Microbes for Vaccine Delivery and Adjuvant Applications: A Review. Gels 2023;9:227. [DOI: 10.3390/gels9030227] [Reference Citation Analysis]
2 Tan RSL, Hassandarvish P, Chee CF, Chan LW, Wong TW. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine. Carbohydr Polym 2022;290:119500. [PMID: 35550778 DOI: 10.1016/j.carbpol.2022.119500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Brannon ER, Guevara MV, Pacifici NJ, Lee JK, Lewis JS, Eniola-adefeso O. Polymeric particle-based therapies for acute inflammatory diseases. Nat Rev Mater. [DOI: 10.1038/s41578-022-00458-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tu B, Wang H, An X, Qu J, Li Q, Gao Y, Shi M, Qiu H, Huang Y. Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. Acta Pharm Sin B 2022. [PMID: 35169535 DOI: 10.1016/j.apsb.2022.01.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Gaspersic J, Dolzan V. Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity. Biology (Basel) 2022;11:178. [PMID: 35205046 DOI: 10.3390/biology11020178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alavi M, Rai M. Strategies on functionalization of organic and inorganic nanocarriers to inactivate SARS-CoV-2. Nanotechnological Applications in Virology 2022. [DOI: 10.1016/b978-0-323-99596-2.00002-9] [Reference Citation Analysis]
7 Sanna V, Satta S, Hsiai T, Sechi M. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
8 Valdivia-Olivares RY, Rodriguez-Fernandez M, Álvarez-Figueroa MJ, Kalergis AM, González-Aramundiz JV. The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines (Basel) 2021;9:1420. [PMID: 34960166 DOI: 10.3390/vaccines9121420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kamat S, Kumari M, Jayabaskaran C. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2. J Control Release 2021;338:813-36. [PMID: 34478750 DOI: 10.1016/j.jconrel.2021.08.046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]